The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts

Authors
Putora, PM
De, RD
Glatzer, M
Widder, J
Van, HP
Troost, EGC
Slotman, BJ
Ramella, S
Pottgen, C
Peeters, S
Affiliation
Department of Radiation Oncology, Kantonsspital St. Gallen, Switzerland;
Issue Date
2019

Metadata
Show full item record
Abstract
BACKGROUND: The role of prophylactic cranial irradiation (PCI) and thoracic radiotherapy (TRT) is unclear in resected small cell lung cancer (SCLC). METHODS: Thirteen European radiotherapy experts on SCLC were asked to describe their strategies on PCI and TRT for patients with resected SCLC. The treatment strategies were converted into decision trees and analyzed for consensus and discrepancies. RESULTS: For patients with resected SCLC and positive lymph nodes most experts recommend prophylactic cranial irradiation and thoracic radiotherapy. For elderly patients with resected node negative SCLC, most experts do not recommend thoracic radiotherapy or prophylactic cranial irradiation. CONCLUSION: PCI and TRT are considered in patients with resected SCLC and these treatments should be discussed with the patient in the context of shared decision-making.
Citation
Putora PM, De Ruysscher D, Glatzer M, Widder J, Van Houtte P, Troost EGC, et al. The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts. Radiother Oncol. 2019;145:45-8.
Journal
Radiotherapy and Oncology
URI
http://hdl.handle.net/10541/622720
DOI
10.1016/j.radonc.2019.11.022
PubMed ID
31887577
Additional Links
https://dx.doi.org/10.1016/j.radonc.2019.11.022
Type
Article
Language
en
Collections